Filing Details
- Accession Number:
- 0000950170-23-005639
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-01 19:01:40
- Reporting Period:
- 2023-02-27
- Accepted Time:
- 2023-03-01 19:01:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1792044 | Viatris Inc | VTRS | Pharmaceutical Preparations (2834) | 834364296 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848812 | (Sean) Xiangyang Ni | 1000 Mylan Boulevard Canonsburg PA 15317 | President, Greater China | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-27 | 12,248 | $0.00 | 41,413 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-02-27 | 894 | $0.00 | 42,307 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-28 | 5,250 | $11.22 | 37,057 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-02-27 | 12,248 | $0.00 | 12,248 | $0.00 |
| Common Stock | Dividend Equivalent Units | Disposition | 2023-02-27 | 894 | $0.00 | 894 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Fractional shares have been rounded up in connection with the settlement described in footnote 5 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
- Shares sold to satisfy the tax liability associated with the vesting and settlement of the RSUs granted on November 16, 2020 and the related dividend equivalent units (DEUs).
- Represents the weighted average price of the reporting person's disposition of 5,250 shares of common stock in transactions ranging from $11.17 to $11.515. The reporting person undertakes to provide to the issuer, anysecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in thisfootnote.
- Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on February 27, 2023.
- Represents DEUs that accrued with respect to the RSUs previously granted on November 16, 2020 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.
Billionaire Hedge Funds
